

Are you experiencing unexplained fatigue, leg swelling, or heart and kidney issues without a clear cause?These could be signs of a rare condition called amyloidosis — a silent disease that gradually affects vital organs.At Daleeli Medical, we uncover everything you need to know about this complex disorder: its types, causes, symptoms, and the latest diagnostic and treatment options — all explained in clear, simple language backed by the most trusted medical sources.
Amyloidosis is a rare disease caused by the abnormal buildup of a protein called amyloid in tissues and organs, leading to gradual dysfunction.
One of the most well-known types is AA amyloidosis, which often occurs in patients with Familial Mediterranean Fever (FMF) who do not take colchicine regularly. In these cases, the body produces excessive amounts of the inflammatory protein AA, which accumulates in the kidneys, liver, heart, and digestive system.
No. Amyloidosis is not contagious and cannot be transmitted from one person to another in any way.
No, it is not a cancer itself. However, some types — like AL amyloidosis — may be associated with plasma cell disorders such as multiple myeloma.
No, it is very rare and often diagnosed late because its symptoms mimic those of many other conditions.
There is no complete cure, but with early and accurate diagnosis, symptoms can be managed and disease progression can be slowed — especially in types like AA or ATTR.
AL amyloidosis is considered the most severe, especially if it affects the heart or kidneys. It requires urgent and specialized treatment.
No. Only hereditary ATTR is genetic. Other types, such as AL and AA, are not inherited.
Type | Cause | Most Affected Organs |
---|---|---|
AL | Plasma cell disorder (light chains) | Heart, kidneys, tongue |
AA | Chronic inflammation (e.g. FMF) | Kidneys, liver |
ATTR | Genetic mutation or aging | Nerves, heart |
Diagnosis involves several key steps:
Tissue biopsy: A sample is taken from an affected area (such as the kidney, rectum, or abdominal fat) and stained with Congo red to detect amyloid deposits.
Blood and urine tests: To determine the specific type of amyloid protein (AL, AA, ATTR).
Organ function evaluation: Includes heart tests (ECG, echocardiogram), kidney and liver function tests, nerve conduction studies, and MRI or ultrasound imaging.
Unusual symptoms that may raise suspicion include:
✅ Heavy protein in the urine (proteinuria) without clear cause
✅ Enlarged tongue (classic sign of AL type)
✅ Progressive unexplained kidney, heart, or nerve dysfunction
✅ Numbness or tingling in hands and feet
✅ Unexplained weight loss or chronic fatigue
Treatment varies based on the type:
Type | Main Treatment |
---|---|
AL | Plasma cell-targeting drugs (e.g., bortezomib, melphalan) ± autologous stem cell transplant |
AA | Control of underlying inflammation (e.g., colchicine for FMF, biologics for chronic disease) |
ATTR (genetic) | Modern drugs like patisiran or inotersen to block abnormal protein production |
ATTR (age-related) | Supportive heart care + symptom management ± stabilizers of amyloid deposits |
In advanced cases, the following may be considered:
Liver transplant (for hereditary ATTR)
Heart or kidney transplant (if severely damaged)
Note: Early diagnosis significantly improves treatment outcomes. Don’t hesitate to seek medical help if you have any concerning symptoms.
Yes. Many patients live for years with amyloidosis, especially with early diagnosis and proper ongoing treatment.
However, in advanced stages — particularly when the heart or kidneys are affected — life expectancy may be reduced.
Yes — the diet depends on the organs involved. Examples:
Low-sodium diet: For heart involvement to reduce fluid retention.
Low-protein diet: For kidney protection.
Vitamin and mineral adjustments: Based on individual needs and lab results.
Consulting a clinical dietitian is essential to customize the meal plan safely and effectively.
Yes, in most cases. Patients can lead a normal life — including traveling and working — if their condition is stable and vital organs are not severely affected.
However, it is important to:
Have regular medical follow-up
Adhere to medications
Consider travel logistics, including access to medical care
Treatment usually involves a multidisciplinary team, depending on the type of amyloidosis and the organs involved. Specialists may include:
Hematology & Immunology
Cardiology ❤️
Neurology
Nephrology (Kidney specialists)
Gastroenterology & Hepatology
Genetic Medicine (for hereditary ATTR cases)
Some groups have a higher risk:
Men are more commonly affected than women
Age over 50 years
Patients with chronic inflammatory diseases (e.g., FMF, rheumatoid arthritis)
Those on long-term dialysis
People with a family history of hereditary amyloidosis
Most cases are diagnosed between 50 and 65 years of age
Hereditary ATTR may present earlier — usually between 40 and 65 years
The age of onset depends on genetics and the presence of chronic diseases
Amyloid protein deposits can damage multiple organs, and symptoms vary based on the type of amyloidosis and the organs involved. The most commonly affected organs include:
One of the most commonly affected organs, especially in AL and ATTR types.
Key manifestations:
Restrictive cardiomyopathy (stiff heart muscle)
Congestive heart failure
Heart rhythm problems (e.g., atrial fibrillation, bradycardia)
Often affected in AL and AA types.
Main symptoms:
Nephrotic syndrome (heavy protein loss in urine)
Fluid retention and swelling
High blood pressure
Chronic kidney failure over time
Involves both peripheral and autonomic nerves, especially in hereditary ATTR.
Common signs:
Numbness or weakness in the limbs
Chronic nerve pain
Drop in blood pressure when standing (orthostatic hypotension)
Digestive and sweating issues
Can involve the esophagus, stomach, intestines, and liver.
Symptoms include:
Nausea, diarrhea or constipation
Gastrointestinal bleeding
Liver enlargement (hepatomegaly)
Abnormal liver function
A classic feature in AL amyloidosis.
Clinical signs:
Macroglossia (enlarged tongue)
Speech or swallowing difficulties
Teeth indentations on the sides of the tongue
Amyloid deposits can cause fragile blood vessels, leading to noticeable skin changes.
Signs:
Periorbital bruising (also called “Raccoon eyes”)
Petechiae (small red or purple spots on the skin)
Easy bruising or bleeding without clear cause
In some cases, the immune system and spleen are affected.
Possible effects:
Splenomegaly (enlarged spleen)
Blood cell abnormalities such as:
Anemia
Low platelets (thrombocytopenia)
Although less common, lung involvement can occur.
Symptoms may include:
Shortness of breath even with minimal exertion
Pleural effusion (fluid buildup around the lungs)
Reduced lung function
Amyloidosis is classified into several main types, depending on the underlying cause, the type of amyloid protein, and the organs involved. Here's an overview:
The most common type in Western countries.
Cause:
A disorder in plasma cells leads to overproduction of light chains of antibodies that deposit in tissues.
Associated with:
Multiple Myeloma
Plasma cell dyscrasias
Organs affected:
Heart, kidneys, nerves, tongue, gastrointestinal tract
Cause:
Chronic inflammation leads to high levels of Serum Amyloid A (SAA) protein.
Associated with:
Rheumatoid arthritis
Crohn’s disease / Ulcerative colitis
Familial Mediterranean Fever (FMF)
Tuberculosis or other chronic infections
Organs affected:
Kidneys, liver, spleen, GI tract
Cause:
A genetic mutation in the transthyretin (TTR) gene.
Inheritance:
Autosomal dominant (inherited from one parent)
Organs affected:
Nerves, heart, gastrointestinal tract
Onset:
Usually between ages 30–60
Cause:
Gradual accumulation of normal (wild-type) transthyretin protein with aging.
Organs affected:
Primarily the heart (causes amyloid cardiomyopathy)
Common in:
Men over 70 years
Often diagnosed only after cardiac symptoms appear
Cause:
Build-up of β2-microglobulin due to incomplete clearance during dialysis.
Organs affected:
Joints, tendons, bones
Seen in:
Patients on long-term dialysis (usually >5 years)
ApoA1 Amyloidosis
Due to mutation in Apolipoprotein A1
Affects: Kidneys, liver
Gelsolin Amyloidosis
Rare inherited type
Affects: Nerves, eyes
Lysozyme Amyloidosis
Genetic
Affects: Liver, kidneys, GI tract
Amyloidosis is sometimes discovered incidentally during testing for another condition, even without symptoms.
Overlap can occur, e.g., AL in myeloma patients or ATTR in elderly individuals.
Precise diagnosis of the amyloid type is critical for proper treatment and prognosis.
Wondering if you're at risk? These are the most recognized risk factors, depending on the type:
Risk increases after age 60
Common in:
ATTRwt (age-related)
AL amyloidosis
Family history of hereditary amyloidosis
Mutations in genes such as:
TTR (transthyretin)
ApoA1
Gelsolin
Symptoms may appear earlier in hereditary types (ATTRm)
Major risk factor for AA Amyloidosis, especially:
Rheumatoid arthritis (RA)
Crohn’s disease / Ulcerative colitis
Familial Mediterranean Fever (FMF)
Tuberculosis or chronic bone infections
Key contributors to AL amyloidosis:
Multiple Myeloma
Plasma cell neoplasms
MGUS (Monoclonal Gammopathy of Undetermined Significance)
These conditions produce light chains, which deposit and cause AL amyloidosis.
Risk increases after >5 years of dialysis
Leads to:
Dialysis-related amyloidosis (Aβ2M)
Deposits in joints and bones
Men are more likely to develop:
ATTRwt (age-related)
AL amyloidosis
7. Ethnicity
The V122I mutation in the TTR gene is common among people of African descent → increases the risk of hereditary ATTR amyloidosis.
8. Immune predisposition
Having autoimmune diseases or a weakened immune system may raise the risk of amyloid protein buildup.
9. Lifestyle (indirect factor)
Examples include:
Poor control of chronic diseases (e.g., diabetes, recurrent UTIs)
Delayed or inappropriate treatment
Environmental factors do not directly cause the disease, but may speed up its progression, especially in genetic types.
Shortness of breath (especially during exertion)
Swelling in the legs or ankles (edema)
Irregular heartbeat (palpitations, atrial fibrillation)
Extreme fatigue
Dizziness or fainting
Chest pain (rare)
Most common in: AL and ATTR types
a) Peripheral nerves:
Numbness or tingling in hands and feet
Burning or electric shock-like pain
Progressive muscle weakness
b) Autonomic nervous system:
Dizziness upon standing (orthostatic hypotension)
Sweating problems
Digestive issues (chronic diarrhea or constipation)
Erectile dysfunction
Difficulty urinating
Most common in: hereditary ATTR (ATTRm)
Leg or ankle swelling
Severe proteinuria
High blood pressure
Progressive kidney failure
Most common in: AL and AA types
Loss of appetite and weight
Nausea or vomiting
Abdominal bloating
Chronic diarrhea or constipation
Enlarged liver (hepatomegaly)
Elevated liver enzymes
More prominent in AL and ATTR types
Classic in AL amyloidosis:
Enlarged tongue (macroglossia)
Teeth indentations on the tongue sides
Trouble speaking or swallowing
Bruising around the eyes (“raccoon eyes”)
Tiny red/purple spots on the skin (petechiae)
Dry eyes or puffy eyelids
Pale or grayish skin discoloration
Typically seen in AL amyloidosis
Joint pain or stiffness
Carpal Tunnel Syndrome:
→ Numbness, pain, and weakness in hands
Common in ATTR
Shortness of breath with activity
Chronic cough
Pleural effusion (fluid around the lungs)
Usually occurs in late-stage or AL type
Fatigue and chronic tiredness
Unexplained weight loss or loss of appetite
Fever of unknown origin
Dark or decreased urine output
Signs of multi-organ failure in advanced stages
Diagnosis starts with recognizing red flags like:
Multiple symptoms across different organs
Unexplained kidney, heart, liver, or nerve issues
Enlarged tongue or unusual skin signs
Nephrotic syndrome without clear cause
a) Tissue Biopsy
Gold standard test using Congo Red staining.
Under polarized light: → shows “apple-green birefringence” → confirms amyloid.
Common biopsy sites:
Site | Benefit |
---|---|
Abdominal fat pad | Simple, first-line for AL diagnosis |
Bone marrow | Useful if blood cancer is suspected |
Kidney or liver | If organ-specific symptoms are present |
Heart muscle biopsy | Only in suspected cardiac involvement |
Essential to choose the right treatment.
Immunohistochemistry
Mass spectrometry → most accurate (AL, AA, ATTR…)
Genetic testing → for hereditary cases (ATTRm)
If AL is suspected:
Serum Free Light Chains (FLC)
Serum/Urine protein electrophoresis (SPEP/UPEP)
Immunofixation electrophoresis (IFE)
Other types:
SAA test → for AA amyloidosis
Troponin & BNP → to assess heart function
Kidney & liver panels → to evaluate organ damage
a) Cardiac evaluation:
Echocardiogram (Echo): shows thickened walls and restrictive motion
Cardiac MRI: highly detailed images of amyloid buildup
PYP Scan: detects ATTR without biopsy
b) Neurologic evaluation:
Nerve conduction studies
Autonomic reflex testing
Recommended when:
Suspecting hereditary ATTR
Family history is present
Early-onset symptoms
a) Kidney involvement:
Reduce salt → minimize fluid retention
Limit protein (if kidney function is low)
Follow doctor's hydration advice
b) Liver or GI involvement:
Small, frequent meals
Avoid greasy or heavy foods
Focus on vitamins (B12, C)
c) Heart involvement:
Low-sodium and low-fluid diet
Avoid caffeine and stimulants
Improves circulation and energy
Enhances flexibility and balance
Avoid strenuous activity in heart or nerve cases
Get enough sleep
Break up daily tasks to avoid exhaustion
Wear comfortable shoes
Try physical therapy
Keep limbs warm in cold weather
Since immunity may be weak:
Regular handwashing
Avoid crowds during low immunity
Get seasonal vaccines (flu, pneumonia)
Join patient support groups
Seek psychological help when needed